Literature DB >> 3838576

Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.

C Dahlöf, P Dahlöf, K Tatemoto, J M Lundberg.   

Abstract

The effect of neuropeptide Y (NPY) on fractional tritium-noradrenaline (3H-NA) release and contractile activity was studied in the isolated portal vein of SHR and WKY rats. NPY (5 X 10(-7) M) enhanced the force of the spontaneous contractile activity by about 40%. The fractional 3H-release elicited by transmural nerve stimulation (TNS), which mainly reflects 3H-NA, was reduced by about 40% after preincubation with 5 X 10(-7) M NPY in portal veins from both SHR and WKY rats. The inhibitory effect of NPY on TNS-evoked 3H-release was more slowly reversed by washout than the facilitatory action on spontaneous contractile force. The contractile response to field stimulation was not reduced by NPY, but rather tended to be increased. It is concluded that NPY exerts a dual action in the SHR and WKY portal vein, thus enhancing the smooth muscle contractions and inhibiting sympathetic neurotransmission. The inhibitory effect of NPY on TNS-evoked NA efflux, which is present in both SHR and WKY rats, is most likely due to a presynaptic site of action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838576     DOI: 10.1007/bf00515562

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

2.  Correlation between noradrenaline release and effector response to nerve stimulation in rat portal vein in vitro.

Authors:  J Häggendal; B Johansson; J Jonason; B Ljung
Journal:  Acta Physiol Scand Suppl       Date:  1970

3.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

Authors:  J M Lundberg; K Tatemoto
Journal:  Acta Physiol Scand       Date:  1982-12

4.  Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat.

Authors:  L F Agnati; K Fuxe; F Benfenati; N Battistini; A Härfstrand; K Tatemoto; T Hökfelt; V Mutt
Journal:  Acta Physiol Scand       Date:  1983-07

5.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

6.  Vasoconstrictor nerve influence on isolated mesenteric resistance vessels from normotensive and spontaneously hypertensive rats.

Authors:  H Nilsson; B Folkow
Journal:  Acta Physiol Scand       Date:  1982-10

7.  Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract.

Authors:  J B Furness; M Costa; P C Emson; R Håkanson; E Moghimzadeh; F Sundler; I L Taylor; R E Chance
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

8.  VIP (vasoactive intestinal polypeptide)--immunoreactive innervation of the portal vein.

Authors:  J Järhult; J Fahrenkrug; P Hellstrand; R Uddman
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

9.  Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens.

Authors:  J M Lundberg; L Stjarne
Journal:  Acta Physiol Scand       Date:  1984-03

10.  Neuropeptide Y in the female reproductive tract of the rat. Distribution of nerve fibres and motor effects.

Authors:  M Stjernquist; P Emson; C Owman; N O Sjöberg; F Sundler; K Tatemoto
Journal:  Neurosci Lett       Date:  1983-09-09       Impact factor: 3.046

View more
  11 in total

Review 1.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity.

Authors:  L E Goehler; C Sternini
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

3.  Chemical sympathectomy reveals pre- and postsynaptic effects of neuropeptide Y (NPY) in the cardiovascular system.

Authors:  Y Mabe; R Pérez; K Tatemoto; J P Huidobro-Toro
Journal:  Experientia       Date:  1987-09-15

4.  Inhibitory effects of neuropeptide Y on sympathetic neurotransmission in the rabbit iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

5.  The effects of age on human venous responsiveness to neuropeptide Y.

Authors:  M L Lambert; I D Callow; Q P Feng; J M Arnold
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

6.  Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.

Authors:  J Pernow; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

7.  Actions of neuropeptide Y on innervated and denervated rat tail arteries.

Authors:  T O Neild
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

8.  Innervation of the large arteries and heart of the toad (Bufo marinus) by adrenergic and peptide-containing neurons.

Authors:  J L Morris; I L Gibbins; G Campbell; R Murphy; J B Furness; M Costa
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

9.  Phylogenetic and ontogenetic study of neuropeptide Y-containing nerves in the liver.

Authors:  W G Ding; I Tooyama; H Kitasato; M Fujimura; H Kimura
Journal:  Histochem J       Date:  1994-05

Review 10.  Peptides in the mammalian cardiovascular system.

Authors:  J Wharton; S Gulbenkian
Journal:  Experientia       Date:  1987-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.